140 related articles for article (PubMed ID: 12224368)
1. Lytic therapy in central venous catheters for hemodialysis.
McFarland HF; Dinwiddie L; Ferrell J; Forloines-Lynn S
Nephrol Nurs J; 2002 Aug; 29(4):355-60; quiz 361-2. PubMed ID: 12224368
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters.
Castner D
Nephrol Nurs J; 2001 Aug; 28(4):403-4, 407-10. PubMed ID: 12143462
[TBL] [Abstract][Full Text] [Related]
3. Does low-dose heparin maintain central venous access device patency?: a comparison of heparin versus saline during a period of heparin shortage.
Jonker MA; Osterby KR; Vermeulen LC; Kleppin SM; Kudsk KA
JPEN J Parenter Enteral Nutr; 2010; 34(4):444-9. PubMed ID: 20631392
[TBL] [Abstract][Full Text] [Related]
4. [Case report: Direct percutaneous placement of tunneled hemodialysis catheter into the inferior vena cava in a patient with dialysis access problem].
Firat A; Aytekin C; Kirbaş I; Boyvat F
Tani Girisim Radyol; 2003 Jun; 9(2):260-2. PubMed ID: 14661499
[TBL] [Abstract][Full Text] [Related]
5. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
6. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.
Clase CM; Crowther MA; Ingram AJ; Cinà CS
J Thromb Thrombolysis; 2001 Apr; 11(2):127-36. PubMed ID: 11406727
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of obstruction and thrombosis due to central venous catheterization].
Leititis JU
Klin Padiatr; 1991; 203(6):420-3. PubMed ID: 1758144
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis of tunneled-cuffed hemodialysis catheters: treatment with high-dose urokinase lock therapy.
Donati G; Colì L; Cianciolo G; La Manna G; Cuna V; Montanari M; Gozzetti F; Stefoni S
Artif Organs; 2012 Jan; 36(1):21-8. PubMed ID: 21848863
[TBL] [Abstract][Full Text] [Related]
9. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
Shavit L; Lifschitz M; Plaksin J; Grenader T; Slotki I
Clin Nephrol; 2010 Oct; 74(4):297-302. PubMed ID: 20875382
[TBL] [Abstract][Full Text] [Related]
10. Alteplase (Cathflo Activase).
Middleton G; Ruzevick B
Clin J Oncol Nurs; 2004 Aug; 8(4):417-8, 420. PubMed ID: 15354930
[No Abstract] [Full Text] [Related]
11. Reteplase for clearance of occluded venous catheters.
Owens L
Am J Health Syst Pharm; 2002 Sep; 59(17):1638-40. PubMed ID: 12224345
[No Abstract] [Full Text] [Related]
12. Nurse's guide to understanding and treating thrombotic occlusion of central venous access devices.
McKnight S
Medsurg Nurs; 2004 Dec; 13(6):377-82. PubMed ID: 15714740
[TBL] [Abstract][Full Text] [Related]
13. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
Jacobs BR; Haygood M; Hingl J
J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
[TBL] [Abstract][Full Text] [Related]
14. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
[No Abstract] [Full Text] [Related]
15. Effect of mechanical brushing on survival and hemodynamic characteristics of tunneled hemodialysis catheters.
Buus NH; Aagaard TG; Mortensen AH; Jensen Jd; Møldrup U; Petersen SE
J Vasc Access; 2012; 13(2):226-30. PubMed ID: 22266590
[TBL] [Abstract][Full Text] [Related]
16. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters.
Atkinson JB; Bagnall HA; Gomperts E
JPEN J Parenter Enteral Nutr; 1990; 14(3):310-1. PubMed ID: 2112648
[TBL] [Abstract][Full Text] [Related]
17. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
EDTNA ERCA J; 2005; 31(2):75-8. PubMed ID: 16180551
[TBL] [Abstract][Full Text] [Related]
18. Techniques in dosing for thrombolysis of occluded central venous catheters.
Haire WD
Tech Vasc Interv Radiol; 2001 Jun; 4(2):127-30. PubMed ID: 11981800
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue plasminogen activator for central venous access device occlusion.
Hooke C
J Pediatr Oncol Nurs; 2000 Jul; 17(3):174-8. PubMed ID: 10944865
[TBL] [Abstract][Full Text] [Related]
20. Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer.
Terrill KR; Lemons RS; Goldsby RE
J Pediatr Hematol Oncol; 2003 Nov; 25(11):864-7. PubMed ID: 14608195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
